Pharma stock play


PETALING JAYA: Rubber glove makers have taken a step back from their dominance of the stock exchange to pave way for pharmaceutical companies, following a shift in interest among investors.

Two research trials in China and the United Kingdom which yielded positive results drove investors into a frenzy to enter pharmaceutical-related companies, not only on Bursa Malaysia but also in key markets globally.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Ringgit expected to trade in tight range against US dollar next week
PKNPk equips SK St Michael students with digital, media skills
Can homes and data centres coexist safely?
Designing haze-ready homes
A new board is not the answer
Trends reshaping premium retail market
A boom centred on data centres
Malaysia’s bonds brace for bumpy ride
Seeking value in Malaysia’s tech rally
Gold holds the hedge

Others Also Read